Stock CBGL CANNABIS GLOBAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cannabis Global, Inc.

Equities

CBGL

US13767G1004

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 03:56:56 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0001 USD +100.00% Intraday chart for Cannabis Global, Inc. 0.00% -50.00%
2023 Cannabis Global, Inc. and KRTL International Corp. Enters into an Exclusive Distribution Agreement CI
2022 Cannabis Global, Inc. Announces the Completion of Research and Development Testing for Infused Drink Straws CI

Valuation

Fiscal Period: August 2016 2017 2018 2019 2020 2021
Capitalization 1 0.006104 0.005027 0.2452 8.416 3.28 3.015
Enterprise Value (EV) 1 0.0711 0.0702 0.3331 8.312 5.644 6.99
P/E ratio -11.7 x -8.95 x -25.9 x -21.1 x -0.42 x -0.26 x
Yield - - - - - -
Capitalization / Revenue - - - - 121,459,413 x 1,883,386 x
EV / Revenue - - - - 209,013,924 x 4,366,232 x
EV / EBITDA - - - -15,134,925 x -1,558,938 x -3,682,229 x
EV / FCF 33.9 x 23.5 x -10.7 x 181 x 14.2 x -7.38 x
FCF Yield 2.95% 4.25% -9.34% 0.55% 7.03% -13.6%
Price to Book -1.14 x -0.85 x -27.3 x 137 x -2.26 x -1.36 x
Nbr of stocks (in thousands) 3,591 3,591 12,258 12,524 27,332 84,940
Reference price 2 0.0255 0.0210 0.3000 0.6720 0.1200 0.0355
Announcement Date 2/2/18 2/20/18 11/29/18 10/21/19 10/27/20 12/14/21
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2016 2017 2018 2019 2020 2021
Net sales - - - - 0.027 1.601
EBITDA - - - -0.5492 -3.621 -1.898
EBIT 1 -0.001558 -0.001431 -0.051 -0.5499 -3.624 -1.944
Operating Margin - - - - -13,419.83% -121.42%
Earnings before Tax (EBT) 1 -0.007825 -0.00843 -0.0868 -0.3896 -4.929 -8.116
Net income 1 -0.007825 -0.00843 -0.0868 -0.3896 -4.929 -7.835
Net margin - - - - -18,254.14% -489.36%
EPS 2 -0.002179 -0.002347 -0.0116 -0.0318 -0.2882 -0.1344
Free Cash Flow 1 0.002096 0.002981 -0.0311 0.0459 0.3967 -0.9474
FCF margin - - - - 1,469.01% -59.18%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/2/18 2/20/18 11/29/18 10/21/19 10/27/20 12/14/21
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: August 2016 2017 2018 2019 2020 2021
Net Debt 1 0.06 0.07 0.09 - 2.36 3.98
Net Cash position 1 - - - 0.1 - -
Leverage (Debt/EBITDA) - - - - -0.653 x -2.094 x
Free Cash Flow 1 0 0 -0.03 0.05 0.4 -0.95
ROE (net income / shareholders' equity) 10.2% 9.94% 77.5% 1,060% 718% 20,423%
ROA (Net income/ Total Assets) -17.9% -18.2% -673% -313% -178% -17.8%
Assets 1 0.0436 0.0464 0.0129 0.1244 2.764 44.06
Book Value Per Share 2 -0.0200 -0.0200 -0.0100 0 -0.0500 -0.0300
Cash Flow per Share 2 0 0 0 0.0100 0 0
Capex - - - 0.01 0.02 0.01
Capex / Sales - - - - 57.4% 0.59%
Announcement Date 2/2/18 2/20/18 11/29/18 10/21/19 10/27/20 12/14/21
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CANNABIS GLOBAL, INC. Stock Cannabis Global, Inc.
-50.00% 392K
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. CBGL Stock
  4. Financials Cannabis Global, Inc.